Company profile: Subtle Medical
1.1 - Company Overview
Company description
- Provider of AI-powered medical imaging software, including SubtleMR to enhance the quality of accelerated MRI protocols through sharpness enhancement and denoising, applicable to nearly all MRI procedures; SubtlePET to use denoising to improve PET image quality in significantly reduced scan time, compatible with all scanner brands; and SubtleGAD to reduce gadolinium dosage for safer contrast-enhanced MRI.
Products and services
- SubtleGAD: AI-powered software reduces gadolinium dosage needed during MRI exams, aiming for safer contrast-enhanced MRI procedures
- SubtleMR: Software-based sharpness enhancement and denoising augment accelerated MRI protocols, applicable to nearly all MRI procedures for improved image quality
- SubtlePET: Vendor-agnostic software employs denoising to improve image quality of PET exams performed in significantly reduced scan time, compatible with all scanner brands
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Subtle Medical
Language & Computing
HQ: United States
Website
- Description: Provider of advanced natural language processing solutions for the healthcare industry, built on a comprehensive biomedical knowledge base to convert unstructured and structured data into meaningful information.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Language & Computing company profile →
Amparex
HQ: Germany
Website
- Description: Provider of a universal cloud solution and cloud-based practice management software for businesses, including a version tailored for audiologists. Solutions offer internet-based access to data and features such as patient file and patient management, statistics, data security, backups, updates, and server hosting.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Amparex company profile →
Biolog-id
HQ: France
Website
- Description: Provider of RFID-enabled identification and traceability solutions for healthcare and life sciences, including Biolog Transfusion, Plasma, and Oncology solutions to track blood, plasma, and oncology injectable preparations; Biolog-Data-System software converting RFID data into real-time actionable information; a Patient Safety Module for correct administration; and data analytics dashboards to support decision-making.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biolog-id company profile →
Olea Medical
HQ: France
Website
- Description: Provider of medical imaging software enabling physicians to obtain results not previously observed, including solutions for emergency imaging analysis, neuro-oncology diagnosis, female pelvic MRI and mammogram diagnostics, APT CEST imaging, functional MRI analysis, and oncology imaging for cancer screening.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Olea Medical company profile →
Biotricity
HQ: United States
Website
- Description: Provider of medical technology solutions aimed at improving healthcare by aiding in chronic disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biotricity company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Subtle Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Subtle Medical
2.2 - Growth funds investing in similar companies to Subtle Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Subtle Medical
4.2 - Public trading comparable groups for Subtle Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →